Bengaluru-Based Lumov Attracts $1.2 Million Seed Round from Incubate Fund Asia, IIMA Ventures, and Angel Investors

Lumov

The Indian healthcare startup ecosystem continues to witness significant investment activity in specialized medical technology segments. Lumov, a Bengaluru based company focused on orthopedic recovery solutions, has successfully secured $1.2 million in seed funding, marking an important milestone in addressing the country’s growing musculoskeletal care needs.

Strategic Investment and Backing

The funding round was spearheaded by Incubate Fund Asia, with notable participation from QRG Investments & Holdings, the family office of Havells. Additional support came from IIMA Ventures, SIDBI, and a consortium of experienced angel investors including Ashish Gupta, Saket Narang, Abhishek Goyal, and Arjun Vaidya. This diverse investor base brings both financial resources and strategic expertise to support Lumov’s growth trajectory.

Addressing Market Gaps

India’s musculoskeletal care sector faces significant challenges, particularly in post surgical rehabilitation and recovery. The market remains largely fragmented, with limited access to specialized recovery products designed for Indian patients. Lumov aims to bridge this gap by developing clinically validated orthopedic recovery and rehabilitation solutions specifically tailored to local patient requirements.

Founded by Saumaric Dangwal and Ankit Gupta, both of whom bring substantial experience from healthcare investing roles at prominent firms including Bain Capital, Brookfield Private Equity, and Steinberg Asset Management, the company leverages deep industry understanding to identify and address critical market needs.

Also Read: Deepinder Goyal Hints That Gravity Could Be the Missing Link Continue Has Found in Understanding Human Aging

Product Development and Partnerships

Lumov’s approach centers on collaboration with orthopedic specialists across India’s leading healthcare institutions. The company has established partnerships with major hospital chains including Manipal, Apollo, Sakra, and AIG. These collaborations enable the development of products that meet clinical standards while addressing real world patient requirements in areas such as post surgical care, pain management, and long-term mobility support.

Growth Plans and Expansion

The fresh capital will fuel multiple growth initiatives. Lumov plans to expand its geographic footprint across Delhi NCR, Hyderabad, and Mumbai, three of India’s largest healthcare markets. The company will strengthen its manufacturing capabilities and sales infrastructure while deepening existing surgeon partnerships. Additionally, resources will be allocated toward accelerating new product development to expand the company’s portfolio of orthopedic recovery solutions.

Currently operating with a core team of fifteen professionals, Lumov anticipates significant hiring across product development, sales, and operations functions. As India’s healthcare infrastructure continues to evolve, specialized solutions in orthopedic recovery represent a critical area of need, positioning Lumov to play a meaningful role in improving patient outcomes across the country.

Also Read: Netflix to Acquire Warner Bros and HBO Max in a Deal Worth $82.7 Billion, Marking One of Hollywood’s Biggest Ever Buyouts

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post
Redapto

Customer Interaction AI Startup Redapto Closes $500,000 Pre-Seed Round Led by Y Combinator

Next Post
Conscious Chemist

D2C Skincare Brand Conscious Chemist Secures Rs 15 Crore in Bridge Funding Led by Atomic Capital

Related Posts
Total
0
Share